Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.
1/5 보강
Despite advances in screening and prevention, cervical cancer remains a frequent cause of cancer-related mortality in women, with current treatments often compromising the patients' quality of life.
APA
Błażejczyk I, Daniluk T, et al. (2026). Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 194, 118928. https://doi.org/10.1016/j.biopha.2025.118928
MLA
Błażejczyk I, et al.. "Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 194, 2026, pp. 118928.
PMID
41496337 ↗
Abstract 한글 요약
Despite advances in screening and prevention, cervical cancer remains a frequent cause of cancer-related mortality in women, with current treatments often compromising the patients' quality of life. Antimicrobial peptides (AMPs) have emerged as promising anticancer agents due to their pleiotropic properties. In the context of cancer development, AMPs are frequently compared to a "double-edged sword", as they can display either anti- or protumorigenic effects. This review explores the biological effects of antimicrobial peptides, both endogenously produced as well as those with non-human source and synthetic ones, for cervical cancer development. The interplay between AMPs, vaginal microbiota, and cervical cancer development is discussed. Finally, we summarize the recent achievements, current challenges and future directions of AMP-based therapies against cervical cancer. While AMPs, both endogenous or synthetically modified, offer significant therapeutic potential, further research is needed to address their end-effect, optimize delivery systems, and validate efficacy, both in vivo and in the clinical setting.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.